Norges Bank Invests $60.39 Million in Maximus, Inc. $MMS

Norges Bank purchased a new position in shares of Maximus, Inc. (NYSE:MMS) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 699,641 shares of the health services provider’s stock, valued at approximately $60,393,000. Norges Bank owned approximately 1.28% of Maximus as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of MMS. Boston Partners raised its holdings in shares of Maximus by 47.0% during the 3rd quarter. Boston Partners now owns 966,139 shares of the health services provider’s stock worth $88,236,000 after buying an additional 308,892 shares in the last quarter. UBS Group AG raised its holdings in shares of Maximus by 76.8% during the 4th quarter. UBS Group AG now owns 610,354 shares of the health services provider’s stock worth $52,686,000 after buying an additional 265,095 shares in the last quarter. Qube Research & Technologies Ltd raised its holdings in shares of Maximus by 115.8% during the 2nd quarter. Qube Research & Technologies Ltd now owns 379,342 shares of the health services provider’s stock worth $26,630,000 after buying an additional 203,521 shares in the last quarter. Assenagon Asset Management S.A. acquired a new position in shares of Maximus during the 4th quarter worth $15,673,000. Finally, Two Sigma Investments LP acquired a new position in shares of Maximus during the 3rd quarter worth $15,397,000. Institutional investors and hedge funds own 97.21% of the company’s stock.

Insider Transactions at Maximus

In other Maximus news, Director Jan Madsen sold 742 shares of the company’s stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total value of $53,609.50. Following the completion of the transaction, the director owned 20,795 shares of the company’s stock, valued at $1,502,438.75. This represents a 3.45% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.80% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

MMS has been the subject of a number of research analyst reports. Wall Street Zen raised Maximus from a “hold” rating to a “buy” rating in a report on Saturday. Zacks Research cut Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, April 27th. Finally, Weiss Ratings cut Maximus from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, May 20th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company currently has an average rating of “Hold”.

Maximus Price Performance

Shares of MMS opened at $60.49 on Monday. Maximus, Inc. has a 12-month low of $56.92 and a 12-month high of $100.00. The business has a 50-day simple moving average of $63.79 and a two-hundred day simple moving average of $76.60. The company has a quick ratio of 2.21, a current ratio of 2.21 and a debt-to-equity ratio of 0.87. The stock has a market cap of $3.18 billion, a PE ratio of 9.06 and a beta of 0.58.

Maximus (NYSE:MMS) last issued its earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.98 by $0.09. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The business had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.32 billion. During the same quarter in the prior year, the firm earned $2.01 EPS. The business’s revenue for the quarter was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Analysts anticipate that Maximus, Inc. will post 8.43 earnings per share for the current fiscal year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend was Friday, May 15th. Maximus’s dividend payout ratio is presently 19.76%.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.